This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Kim Stuyckens: Innovator in Cancer Treatment
Introduction
Kim Stuyckens is a notable inventor based in Heist-op-den-Berg, Belgium. He has made significant contributions to the field of cancer treatment, particularly through his innovative work involving erdafitinib. His dedication to advancing medical science has led to the development of a patented method that aims to improve cancer therapies.
Latest Patents
Kim Stuyckens holds 1 patent for his invention related to cancer treatment. This patent outlines a method for treating cancer using erdafitinib, showcasing his commitment to finding effective solutions for patients battling this disease.
Career Highlights
Stuyckens is currently employed at Janssen Pharmaceutica NV, a leading pharmaceutical company known for its research and development in innovative healthcare solutions. His role at Janssen has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to cancer treatment.
Collaborations
Throughout his career, Kim has worked alongside esteemed colleagues such as Yohann Loriot and Anjali Narayan Avadhani. Their collaborative efforts have been instrumental in advancing research and developing new treatment methodologies.
Conclusion
Kim Stuyckens exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. His work not only reflects his expertise but also his commitment to improving patient outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile